A federal appeals court panel kept questions to a minimum Tuesday during oral arguments between Medtronic Inc. and the IRS over the best method for pricing the medical device maker’s transactions with ...

Medtronic PLC closed 10.85% short of its 52-week high of $96.25, which the company reached on March 10th.

BOSTON, MA / ACCESS Newswire / April 25, 2025 / Cowper Law LLP has successfully defeated Medtronic Inc's Motion for Summary Judgment based on statute of limitations in the case Davis et al.

Medtronic plc MDT is scheduled to report fourth-quarter and full-year fiscal 2025 results on May 21, before the opening bell. In the last reported quarter, the company’s adjusted earnings of $1. ...

Piper Sandler analyst Matthew O’Brien maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $90.00. The company’s shares closed last Thursday at $82.60.

MM+M Women of Distinction honoree, announced Monday morning that she has joined Medtronic Diabetes as its chief marketing ...

TD Cowen analyst Josh Jennings maintained a Buy rating on Medtronic (MDT – Research Report) today and set a price target of $95.00. The company’s shares closed yesterday at $84.30. Discover ...

Medtronic plc (NYSE: MDT), a leading global healthcare technology company, stands out as a compelling option. It offers a distinctive combination of defensive traits and growth opportunities ...

The first-ever pacemaker to include Managed Ventricular Pacing (MVP®), the EnRhythm™ Pacing System promotes intrinsic conduction and is clinically proven to significantly reduce unnecessary ...